Wet Age-Related Macular Degeneration

All lots of bevacizumab 1.25 mg/0.05 mL 31-gauge injectable and bevacizumab 2.5 mg/0.1 mL Normject TB injectable from Pacifico National, doing business as AmEx Pharmacy, have been voluntarily recalled by the company, according to a press release.

The FDA has approved a chemistry, manufacturing and controls prior-approval supplement for the Eylea injection prefilled syringe, Regeneron announced in a press release.

Healio spoke with Rishi P. Singh, MD, to discuss the variety of treatments in both dry and wet age-related macular degeneration, including the recent FDA approvals of faricimab-svoa and ranibizumab injection, and the biggest challenges in treating neovascular AMD.

Healio spoke with Rishi P. Singh, MD, to discuss the variety of treatments in both dry and wet age-related macular degeneration, including the recent FDA approvals of faricimab-svoa and ranibizumab injection, and the biggest challenges in treating neovascular AMD.

Healio spoke with Rishi P. Singh, MD, to discuss the variety of treatments in both dry and wet age-related macular degeneration, including the recent FDA approvals of faricimab-svoa and ranibizumab injection, and the biggest challenges in treating neovascular AMD.

Healio spoke with Rishi P. Singh, MD, to discuss the variety of treatments in both dry and wet age-related macular degeneration, including the recent FDA approvals of faricimab-svoa and ranibizumab injection, and the biggest challenges in treating neovascular AMD.

Healio spoke with Rishi P. Singh, MD, to discuss the variety of treatments in both dry and wet age-related macular degeneration, including the recent FDA approvals of faricimab-svoa and ranibizumab injection, and the biggest challenges in treating neovascular AMD.

Healio spoke with Rishi P. Singh, MD, to discuss the variety of treatments in both dry and wet age-related macular degeneration, including the recent FDA approvals of faricimab-svoa and ranibizumab injection, and the biggest challenges in treating neovascular AMD.

Healio spoke with Avni P. Finn, MD, MBA, assistant professor at Vanderbilt University and vitreoretinal surgeon at Northern California Retina Vitreous Associates, about the progression of treatment options for age-related macular degeneration.

Healio spoke with Avni P. Finn, MD, MBA, assistant professor at Vanderbilt University and vitreoretinal surgeon at Northern California Retina Vitreous Associates, about the progression of treatment options for age-related macular degeneration.